GI Oncology
From the Journals
Colorectal tumors: ESD passes long-term test
In superficial colorectal tumors, over a minimum of 5 years of follow-up, endoscopic submucosal dissection was effective and generally safe.
From the Journals
Barrett’s esophagus: Cancer risk is highest in first year after diagnosis
Catch Barrett’s esophagus early to prevent adenocarcinoma.
Feature
Colorectal cancer mortality highest in W.Va., lowest in Utah
More than 50,000 colorectal cancer deaths are expected in the United States for 2017, according to the American Cancer Society.
From the Journals
‘Strong evidence’ links obesity to cancers
A large umbrella review study of more than 200 meta-analyses finds that obesity is associated with a wide range of cancers.
From the Journals
Rectal cancer proportion in young doubled
Colorectal cancer has been a “good news” story over the past 10-15 years. In the United States we have seen 30% reduction in both incidence and...
From the Journals
Study supports multigene germline testing in colorectal cancer
About 10% of patients with colorectal cancer had at least one germline mutation known to increase the risk of cancer, according to results from a...
Conference Coverage
Nivolumab shows promise for pretreated advanced HCC
SAN FRANCISCO – Nivolumab was associated with durable responses in heavily pretreated patients with advanced hepatocellular carcinoma in the dose-...
Conference Coverage
Adjuvant GEMOX disappoints for localized biliary tract cancer
SAN FRANCISCO – Postsurgery adjuvant treatment with gemcitabine and oxaliplatin (GEMOX) was feasible, but failed to significantly improve relapse-...
Conference Coverage
Breath test aims to sniff out GEJ cancers
AMSTERDAM
Conference Coverage
Hand-foot syndrome less with S-1 than capecitabine in mCRC
AMSTERDAM – S-1 was associated with a lower incidence of hand-foot syndrome than was capecitabine in patients with metastatic colorectal cancer....